Modular Medical (MODD) announced the 510(k) premarket submission of its next generation Pivot tubeless patch pump to the U.S. Food and Drug Administration. The Company expects to commence the commercial launch of its Pivot pump in Q1 2026.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MODD:
- Modular Medical announces validation of Pivot controller line
- Modular Medical announces ‘ongoing progress’ to obtain CE Mark
- Modular Medical appoints David Bosshard as head of international operations
- Modular Medical announces exercise of warrants for $4.4M in proceeds
- Modular Medical Announces Strategic Warrant Exercise Agreement